Abstract
Aims: Treosulfan is an alkylating agent increasingly used prior to haematopoietic stem cell transplantation. The aim of this study was to develop a population pharmacokinetic (PK) model of treosulfan in paediatric haematopoietic stem cell transplantation recipients and to explore the effect of potential covariates on treosulfan PK. Also, a limited sampling model (LSM) will be developed to accurately predict treosulfan exposure suitable for a therapeutic drug monitoring setting. Methods: In this multicentre study, 91 patients, receiving a total dose of 30, 36 or 42 g/m2 treosulfan, administered over 3 consecutive days, were enrolled. A population PK model was developed and demographic factors, as well as laboratory parameters, were included as potential covariates. In addition, a LSM was developed using data from 28 patients. Results: A 2-compartment model with first order elimination best described the data. Bodyweight with allometric scaling and maturation function were identified as significant predictors of treosulfan clearance. Treosulfan clearance reaches 90% of adult values at 4 postnatal years. A model-based dosing table is presented to target an exposure of 1650 mg*h/L (population median) for different weight and age groups. Samples taken at 1.5, 4 and 7 hours after start of infusion resulted in the best limited sampling strategy. Conclusions: This study provides a treosulfan population PK model in children and captures the developmental changes in clearance. A 3-point LSM allows for accurate and precise estimation of treosulfan exposure.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 2033-2044 |
| Numero di pagine | 12 |
| Rivista | British Journal of Clinical Pharmacology |
| Volume | 85 |
| Numero di pubblicazione | 9 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2019 |
All Science Journal Classification (ASJC) codes
- Farmacologia
- Farmacologia (medica)
Keywords
- conditioning regimen
- haematopoietic stem cell transplantation
- paediatric patients
- population pharmacokinetics
- treosulfan
Fingerprint
Entra nei temi di ricerca di 'Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver